566 JOURNAL OF COSMETIC SCIENCE
to their habitat. Indeed, most of them are able to thrive in poorly nutritious conditions,
essentially dry, characterized by an acidic pH (around five) and exposed to varying climatic
conditions (ultraviolet radiations or UV, temperature, etc.).3 Despite a great variability in
the composition of the skin microbiota from one individual to another, common features
are described. On the face, the most abundant genera are Cutibacterium sp. (formerly
known as Propionibacterium sp.), coagulase-negative Staphylococci (CoNS), Corynebacterium sp.,4
Micrococcus sp. and Streptococcus sp.1
Most microorganisms are not harmful and some are known to benefit their host.5 For
instance, they can inhibit pathogens through nutrient competition or the secretion of
harmful molecules like bacteriocins.5 They can also play a role in the immune system
training, or contribute to the maintenance of the barrier function.6 Hence, the microbiota,
in symbiosis with its host, plays an important role for the skin. Nonetheless, the skin
is constantly exposed to harsh environmental conditions or to pollutants or xenobiotic
substances that can alter the homeostasis of this ecosystem.7,8 It has been reported that
the regular use of hygienic products can alter the skin microbiota.9–11 Most cosmetics also
contain preservatives to prevent the proliferation of potential pathogens.12
To ensure that cosmetic products are not harmful to the skin microbiota, researchers have
designed a variety of assays, as described hereafter. Some commercial solutions (“Microbiome
Friendly” certifications by My Microbiome or Byome Labs “Microbiome-Friendly+” seal
from Labskin, etc.)—more or less complex—are already proposed by contractors. The most
common assays consist in putting into contact a cosmetic ingredient or a formulation with
targeted commensal species of the skin (e.g., Staphylococcus epidermidis, Cutibacterium acnes,
Corynebacterium spp., etc.).14 These methods are easy and rapid to implement.13 However,
they are often achieved by working with microorganisms from collections, such as the
American Type Culture Collection (ATCC) or the Biological Resource Center of Institut
Pasteur (CRBIP) and grown in optimal laboratory conditions that are not relevant to the
conditions found on the skin. Moreover, they do not take into consideration the fact that
the skin microbiota is a consortium of several species interacting with each other.
Some models gain in complexity by depositing tested products on 3D (three-dimensional)
skin models colonized by microorganisms.13,15 Here, not only can the microorganisms
be analyzed following the adjunction of products, but also the impact on the skin
tissues. Another advantage is that several species of microorganisms can be inoculated
simultaneously on a reconstructed human epidermis (RHE), hence mimicking the skin
microbiota and giving more relevance to the test. However, mixing more than three
different species in 3D models is a technical challenge.
Finally, the “friendliness” of a product is sometimes evaluated through clinical assays. With
the use of next generation sequencing techniques, such trials offer accurate data about the
formulas’ effect on the microbiome.9,6 Nevertheless, the screening of multiple ingredients
can hardly be achieved with a single clinical trial, and this method seems more appropriate
for finished products.
The present work aims at designing an in vitro model to test the ability of cosmetic ingredients
to preserve the microbiota, and takes into account the complexity and specificity of the skin
ecosystem. Wild isolates from the main species of the human face microbiota (Cutibacterium
acnes, Staphyloccocus epidermidis, Corynebacterium xerosis, Micrococcus luteus, and Streptococcus
mitis) were collected from healthy individuals. Given the environmental conditions found
on the skin, the aim was to develop a coculture protocol (pH near 5.5, temperature near
to their habitat. Indeed, most of them are able to thrive in poorly nutritious conditions,
essentially dry, characterized by an acidic pH (around five) and exposed to varying climatic
conditions (ultraviolet radiations or UV, temperature, etc.).3 Despite a great variability in
the composition of the skin microbiota from one individual to another, common features
are described. On the face, the most abundant genera are Cutibacterium sp. (formerly
known as Propionibacterium sp.), coagulase-negative Staphylococci (CoNS), Corynebacterium sp.,4
Micrococcus sp. and Streptococcus sp.1
Most microorganisms are not harmful and some are known to benefit their host.5 For
instance, they can inhibit pathogens through nutrient competition or the secretion of
harmful molecules like bacteriocins.5 They can also play a role in the immune system
training, or contribute to the maintenance of the barrier function.6 Hence, the microbiota,
in symbiosis with its host, plays an important role for the skin. Nonetheless, the skin
is constantly exposed to harsh environmental conditions or to pollutants or xenobiotic
substances that can alter the homeostasis of this ecosystem.7,8 It has been reported that
the regular use of hygienic products can alter the skin microbiota.9–11 Most cosmetics also
contain preservatives to prevent the proliferation of potential pathogens.12
To ensure that cosmetic products are not harmful to the skin microbiota, researchers have
designed a variety of assays, as described hereafter. Some commercial solutions (“Microbiome
Friendly” certifications by My Microbiome or Byome Labs “Microbiome-Friendly+” seal
from Labskin, etc.)—more or less complex—are already proposed by contractors. The most
common assays consist in putting into contact a cosmetic ingredient or a formulation with
targeted commensal species of the skin (e.g., Staphylococcus epidermidis, Cutibacterium acnes,
Corynebacterium spp., etc.).14 These methods are easy and rapid to implement.13 However,
they are often achieved by working with microorganisms from collections, such as the
American Type Culture Collection (ATCC) or the Biological Resource Center of Institut
Pasteur (CRBIP) and grown in optimal laboratory conditions that are not relevant to the
conditions found on the skin. Moreover, they do not take into consideration the fact that
the skin microbiota is a consortium of several species interacting with each other.
Some models gain in complexity by depositing tested products on 3D (three-dimensional)
skin models colonized by microorganisms.13,15 Here, not only can the microorganisms
be analyzed following the adjunction of products, but also the impact on the skin
tissues. Another advantage is that several species of microorganisms can be inoculated
simultaneously on a reconstructed human epidermis (RHE), hence mimicking the skin
microbiota and giving more relevance to the test. However, mixing more than three
different species in 3D models is a technical challenge.
Finally, the “friendliness” of a product is sometimes evaluated through clinical assays. With
the use of next generation sequencing techniques, such trials offer accurate data about the
formulas’ effect on the microbiome.9,6 Nevertheless, the screening of multiple ingredients
can hardly be achieved with a single clinical trial, and this method seems more appropriate
for finished products.
The present work aims at designing an in vitro model to test the ability of cosmetic ingredients
to preserve the microbiota, and takes into account the complexity and specificity of the skin
ecosystem. Wild isolates from the main species of the human face microbiota (Cutibacterium
acnes, Staphyloccocus epidermidis, Corynebacterium xerosis, Micrococcus luteus, and Streptococcus
mitis) were collected from healthy individuals. Given the environmental conditions found
on the skin, the aim was to develop a coculture protocol (pH near 5.5, temperature near











































































































































